|
KMID : 0371420180950030161
|
|
Annals of Surgical Treatment and Research
2018 Volume.95 No. 3 p.161 ~ p.167
|
|
|
Protective effect of Korean red ginseng on oxaliplatin-mediated splenomegaly in colon cancer
|
|
Kang Jeong-Hyun
Park Joon-Seong
Ahn Sung-Gwe
Lim Jin-Hong
Baik Seung-Hyuk
Yoon Dong-Sup
Lee Kang-Young
Jeong Joon
|
|
|
Abstract
|
|
|
Purpose: This study investigated how adding Korean red ginseng extract (KRG) to folinic acid, fluorouracil and oxaliplatin (FOLFOX) chemotherapy affected the rate of splenomegaly in colon cancer.
Methods: This retrospective study analyzed 42 patients who were randomly assigned to receive a FOLFOX regimen with or without KRG. Spleen volume change was assessed by computed tomography scans measured before surgery (presurgery volume) and 3 weeks after cessation of the 12th cycle of FOLFOX (postchemotherapy volume).
Results: All patients showed increased spleen volume. No difference was observed in median presurgery and postchemotherapy volume between the KRG and control groups. However, a ratio defined as postchemotherapy volume divided by presurgery volume was significantly lower in the KRG group than the control group (median, 1.38 [range, 1.0?2.8] in KRG group vs. median, 1.89 [range, 1.1?3.0] in control group, P = 0.028). When splenomegaly was defined as a >61% increase in spleen volume, the rate of splenomegaly was significantly lower in the KRG group than the control group (28.6% vs. 61.9%, P = 0.03). KRG consumption was inversely associated with developing splenomegaly in multivariate analysis.
Conclusion: Adding KRG during FOLFOX chemotherapy for colon cancer might protect against oxaliplatin-induced splenomegaly. The protective effect of Korean red ginseng should be investigated with further research.
|
|
|
KEYWORD
|
|
|
Oxaliplatin, Splenomegaly, Colonic neoplasms, Folfox protocol
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
   
|